Cite
HARVARD Citation
Pengo, V. et al. (2016). Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial. Lupus. pp. 301-306. [Online].